Christoph Tondera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Christoph Tondera has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Jens Pietzsch
Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany
8 shared publications - Ivan Rusev Minev
Division of Polymer Biomaterials Science Leibniz Institute for Polymer Research Dresden Dresden Germany
6 shared publications - Markus Laube
Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, 01328 Dresden, Germany
4 shared publications - Andreas Lendlein
Institute of Active Polymers, Helmholtz-Zentrum Hereon, Kantstr. 55, 14513 Teltow, Germany
3 shared publications - Axel Thomas Neffe
Institute of Materials Chemistry, BTU Cottbus-Senftenberg, Universitätsplatz 1, 01968 Senftenberg, Germany
3 shared publications - Torsten Kniess
Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany
3 shared publications
Latest Publications
- Open Access
- 1 June 2026
- Published by IOP Publishing in Nano Futures
- Vol. 10 (2) , 022001
Nano-enabled living materials and living electronics: a roadmap for innovation and impact
Nano-enabled living materials and living electronics represent the next frontier in integrating biology with advanced nanotechnology, offering unprecedented opportunities to design systems with programmable, adaptive, and multifunctional capabilities. By combining living cells or tissues with engineered nanostructures, living materials and electronics create platforms for bi-directional communication, sensing, and actuation. These advancements hold immense potential for applications in healthcare, energy systems, and environmental sustainability. This roadmap provides a comprehensive vision for advancing this transformative field, addressing scientific challenges, technological pathways, and long-term goals for deploying these hybrid systems at scale.
- 1 June 2026
- Published by IOP Publishing in Nano Futures
- Vol. 10 (2) , 022001
Open AccessNano-enabled living materials and living electronics: a roadmap for innovation and impact
Nano-enabled living materials and living electronics represent the next frontier in integrating biology with advanced nanotechnology, offering unprecedented opportunities to design systems with programmable, adaptive, and multifunctional capabilities. By combining living cells or tissues with engineered nanostructures, living materials and electronics create platforms for bi-directional communication, sensing, and actuation. These advancements hold immense potential for applications in healthcare, energy systems, and environmental sustainability. This roadmap provides a comprehensive vision for advancing this transformative field, addressing scientific challenges, technological pathways, and long-term goals for deploying these hybrid systems at scale.
- Open Access
- 11 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Transforming healthcare through in-body bioelectronic systems
Recent advances in the development of in-body bioelectronic systems are providing new opportunities for the clinical management of various diseases and disorders. These emerging technologies are tailored to specific organs and are beginning to blend both diagnostic sensing and therapeutic actuation. The aim of these systems is to seamlessly integrate with the physiological environment, as illustrated by the diverse device strategies discussed throughout this article. Next generation modalities, such as optogenetics combining gene therapy with devices for photostimulation, are gaining popularity and offer advantages over existing therapeutic strategies. In this perspective, we explore the current state of technological developments, key challenges in the field and potential pathways for translating these innovations into clinical practice.
- 11 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessTransforming healthcare through in-body bioelectronic systems
Recent advances in the development of in-body bioelectronic systems are providing new opportunities for the clinical management of various diseases and disorders. These emerging technologies are tailored to specific organs and are beginning to blend both diagnostic sensing and therapeutic actuation. The aim of these systems is to seamlessly integrate with the physiological environment, as illustrated by the diverse device strategies discussed throughout this article. Next generation modalities, such as optogenetics combining gene therapy with devices for photostimulation, are gaining popularity and offer advantages over existing therapeutic strategies. In this perspective, we explore the current state of technological developments, key challenges in the field and potential pathways for translating these innovations into clinical practice.
- Open Access
- 26 March 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (40) , e72866
Conductive Hydrogels for Exogenous Sensing and Cell Fate Control
Next generation technologies linking living systems to computers will require materials built on biology, an approach that may address persistent challenges in stable and multimodal information exchange. Here, we present a semi‐synthetic hydrogel, designed to emulate key features of native extracellular matrix (ECM) while offering electrically tunable functionality. We engineer interactions between sulfated glycosaminoglycans (sGAGs) and a semiconducting organic polymer (poly(3,4‐ethylenedioxythiophene), PEDOT) within a soft hydrogel network (PEDOT:sGAGh). We demonstrate control over the material's nanoarchitecture, electrochemical behavior, and biomolecular interactions. In particular, PEDOT:sGAGh exhibits affinity for bioactive proteins, including growth factors, and allows their release or retention to be modulated by low‐voltage stimulation. This enables electrical control over macromolecular cues for cell differentiation, a capability not found in natural ECM or conventional conductive hydrogels. These functions are achieved with ultra‐low PEDOT content (≈1 wt.%), preserving the hydrogel's tissue‐like softness and high water content. The PEDOT:sGAGh material can be integrated as a bioactive coating on electrodes, or into 3D organic electrochemical transistors (OECTs). Our results position PEDOT:sGAGh as a versatile platform for realizing biohybrid circuits that bridge molecular signaling and solid‐state electronics, thus paving the way for brain‐machine interfaces that operate beyond purely electrical modes of interaction.
- 26 March 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (40) , e72866
Open AccessConductive Hydrogels for Exogenous Sensing and Cell Fate Control
Next generation technologies linking living systems to computers will require materials built on biology, an approach that may address persistent challenges in stable and multimodal information exchange. Here, we present a semi‐synthetic hydrogel, designed to emulate key features of native extracellular matrix (ECM) while offering electrically tunable functionality. We engineer interactions between sulfated glycosaminoglycans (sGAGs) and a semiconducting organic polymer (poly(3,4‐ethylenedioxythiophene), PEDOT) within a soft hydrogel network (PEDOT:sGAGh). We demonstrate control over the material's nanoarchitecture, electrochemical behavior, and biomolecular interactions. In particular, PEDOT:sGAGh exhibits affinity for bioactive proteins, including growth factors, and allows their release or retention to be modulated by low‐voltage stimulation. This enables electrical control over macromolecular cues for cell differentiation, a capability not found in natural ECM or conventional conductive hydrogels. These functions are achieved with ultra‐low PEDOT content (≈1 wt.%), preserving the hydrogel's tissue‐like softness and high water content. The PEDOT:sGAGh material can be integrated as a bioactive coating on electrodes, or into 3D organic electrochemical transistors (OECTs). Our results position PEDOT:sGAGh as a versatile platform for realizing biohybrid circuits that bridge molecular signaling and solid‐state electronics, thus paving the way for brain‐machine interfaces that operate beyond purely electrical modes of interaction.
- 21 September 2020
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 4 (10) , 1010-1022
Rapid prototyping of soft bioelectronic implants for use as neuromuscular interfaces
Neuromuscular interfaces are required to translate bioelectronic technologies for application in clinical medicine. Here, by leveraging the robotically controlled ink-jet deposition of low-viscosity conductive inks, extrusion of insulating silicone pastes and in situ activation of electrode surfaces via cold-air plasma, we show that soft biocompatible materials can be rapidly printed for the on-demand prototyping of customized electrode arrays well adjusted to specific anatomical environments, functions and experimental models. We also show, with the monitoring and activation of neuronal pathways in the brain, spinal cord and neuromuscular system of cats, rats and zebrafish, that the printed bioelectronic interfaces allow for long-term integration and functional stability. This technology might enable personalized bioelectronics for neuroprosthetic applications.
- 21 September 2020
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 4 (10) , 1010-1022
Rapid prototyping of soft bioelectronic implants for use as neuromuscular interfaces
Neuromuscular interfaces are required to translate bioelectronic technologies for application in clinical medicine. Here, by leveraging the robotically controlled ink-jet deposition of low-viscosity conductive inks, extrusion of insulating silicone pastes and in situ activation of electrode surfaces via cold-air plasma, we show that soft biocompatible materials can be rapidly printed for the on-demand prototyping of customized electrode arrays well adjusted to specific anatomical environments, functions and experimental models. We also show, with the monitoring and activation of neuronal pathways in the brain, spinal cord and neuromuscular system of cats, rats and zebrafish, that the printed bioelectronic interfaces allow for long-term integration and functional stability. This technology might enable personalized bioelectronics for neuroprosthetic applications.
- Open Access
- 16 July 2020
- Published by Springer Nature in npj Flexible Electronics
- Vol. 4 (1) , 1-8
Printed elastic membranes for multimodal pacing and recording of human stem-cell-derived cardiomyocytes
Bioelectronic interfaces employing arrays of sensors and bioactuators are promising tools for the study, repair and engineering of cardiac tissues. They are typically constructed from rigid and brittle materials processed in a cleanroom environment. An outstanding technological challenge is the integration of soft materials enabling a closer match to the mechanical properties of biological cells and tissues. Here we present an algorithm for direct writing of elastic membranes with embedded electrodes, optical waveguides and microfluidics using a commercial 3D printing system and a palette of silicone elastomers. As proof of principle, we demonstrate interfacing of cardiomyocytes derived from human induced pluripotent stem cells (hiPSCs), which are engineered to express Channelrhodopsin-2. We demonstrate electrical recording of cardiomyocyte field potentials and their concomitant modulation by optical and pharmacological stimulation delivered via the membrane. Our work contributes a simple prototyping strategy with potential applications in organ-on-chip or implantable systems that are multi-modal and mechanically soft.
- 16 July 2020
- Published by Springer Nature in npj Flexible Electronics
- Vol. 4 (1) , 1-8
Open AccessPrinted elastic membranes for multimodal pacing and recording of human stem-cell-derived cardiomyocytes
Bioelectronic interfaces employing arrays of sensors and bioactuators are promising tools for the study, repair and engineering of cardiac tissues. They are typically constructed from rigid and brittle materials processed in a cleanroom environment. An outstanding technological challenge is the integration of soft materials enabling a closer match to the mechanical properties of biological cells and tissues. Here we present an algorithm for direct writing of elastic membranes with embedded electrodes, optical waveguides and microfluidics using a commercial 3D printing system and a palette of silicone elastomers. As proof of principle, we demonstrate interfacing of cardiomyocytes derived from human induced pluripotent stem cells (hiPSCs), which are engineered to express Channelrhodopsin-2. We demonstrate electrical recording of cardiomyocyte field potentials and their concomitant modulation by optical and pharmacological stimulation delivered via the membrane. Our work contributes a simple prototyping strategy with potential applications in organ-on-chip or implantable systems that are multi-modal and mechanically soft.
- 7 October 2019
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 5 (11) , 5979-5989
Characterization of Tissue Transglutaminase as a Potential Biomarker for Tissue Response toward Biomaterials
Tissue transglutaminase (TGase 2) is proposed to be important for biomaterial-tissue interactions due to its presence and versatile functions in the extracellular environment. TGase 2 catalyzes the crosslinking of proteins through its Ca2+-dependent acyltransferase activity. Moreover, it enhances the interactions between fibronectin and integrins, which in turn mediates the adhesion, migration and motility of the cells. TGase 2 is also a key player in the pathogenesis of fibrosis. In this study, we investigated whether TGase 2 is present at the biomaterial-tissue interface and might serve as an informative biomarker for the visualization of tissue response towards gelatin-based biomaterials. Two differently crosslinked hydrogels were used, which were obtained by reaction of gelatin with lysine diisocyanate ethyl ester. The overall expression of TGase 2 by endothelial cells, macrophages and granulocytes was partly influenced by contact to the hydrogels or their degradation products, although no clear correlation was evidenced. In contrast, secretion of TGase 2 differed remarkably between the different cells, indicating that it might be involved in the cellular reaction towards gelatin-based hydrogels. The hydrogels were implanted subcutaneously in immunocompetent, hairless SKH1-Elite mice. Ex vivo immunohistochemical analysis of tissue sections over 112 days revealed enhanced expression of TGase 2 around the hydrogels, in particular at days 14 and 21 post implantation. The incorporation of fluorescently labeled cadaverine derivatives for detection of active TGase 2, was in accordance to the results of the expression analysis. The presence of an irreversible inhibitor of TGase 2 led to attenuated incorporation of the cadaverines, which verified the catalytic action of TGase 2. Our in vitro and ex vivo results verified TGase 2 as a potential biomarker for tissue response towards gelatin-based hydrogels. In vivo, no TGase 2 activity was detectable, which is mainly attributed to the unfavorable physicochemical properties of the cadaverine probe used.
- 7 October 2019
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 5 (11) , 5979-5989
Characterization of Tissue Transglutaminase as a Potential Biomarker for Tissue Response toward Biomaterials
Tissue transglutaminase (TGase 2) is proposed to be important for biomaterial-tissue interactions due to its presence and versatile functions in the extracellular environment. TGase 2 catalyzes the crosslinking of proteins through its Ca2+-dependent acyltransferase activity. Moreover, it enhances the interactions between fibronectin and integrins, which in turn mediates the adhesion, migration and motility of the cells. TGase 2 is also a key player in the pathogenesis of fibrosis. In this study, we investigated whether TGase 2 is present at the biomaterial-tissue interface and might serve as an informative biomarker for the visualization of tissue response towards gelatin-based biomaterials. Two differently crosslinked hydrogels were used, which were obtained by reaction of gelatin with lysine diisocyanate ethyl ester. The overall expression of TGase 2 by endothelial cells, macrophages and granulocytes was partly influenced by contact to the hydrogels or their degradation products, although no clear correlation was evidenced. In contrast, secretion of TGase 2 differed remarkably between the different cells, indicating that it might be involved in the cellular reaction towards gelatin-based hydrogels. The hydrogels were implanted subcutaneously in immunocompetent, hairless SKH1-Elite mice. Ex vivo immunohistochemical analysis of tissue sections over 112 days revealed enhanced expression of TGase 2 around the hydrogels, in particular at days 14 and 21 post implantation. The incorporation of fluorescently labeled cadaverine derivatives for detection of active TGase 2, was in accordance to the results of the expression analysis. The presence of an irreversible inhibitor of TGase 2 led to attenuated incorporation of the cadaverines, which verified the catalytic action of TGase 2. Our in vitro and ex vivo results verified TGase 2 as a potential biomarker for tissue response towards gelatin-based hydrogels. In vivo, no TGase 2 activity was detectable, which is mainly attributed to the unfavorable physicochemical properties of the cadaverine probe used.
- Open Access
Highly Conductive, Stretchable, and Cell‐Adhesive Hydrogel by Nanoclay Doping
Electrically conductive materials that mimic physical and biological properties of tissues are urgently required for seamless brain–machine interfaces. Here, a multinetwork hydrogel combining electrical conductivity of 26 S m−1, stretchability of 800%, and tissue‐like elastic modulus of 15 kPa with mimicry of the extracellular matrix is reported. Engineering this unique set of properties is enabled by a novel in‐scaffold polymerization approach. Colloidal hydrogels of the nanoclay Laponite are employed as supports for the assembly of secondary polymer networks. Laponite dramatically increases the conductivity of in‐scaffold polymerized poly(ethylene‐3,4‐diethoxy thiophene) in the absence of other dopants, while preserving excellent stretchability. The scaffold is coated with a layer containing adhesive peptide and polysaccharide dextran sulfate supporting the attachment, proliferation, and neuronal differentiation of human induced pluripotent stem cells directly on the surface of conductive hydrogels. Due to its compatibility with simple extrusion printing, this material promises to enable tissue‐mimetic neurostimulating electrodes.
Open AccessHighly Conductive, Stretchable, and Cell‐Adhesive Hydrogel by Nanoclay Doping
Electrically conductive materials that mimic physical and biological properties of tissues are urgently required for seamless brain–machine interfaces. Here, a multinetwork hydrogel combining electrical conductivity of 26 S m−1, stretchability of 800%, and tissue‐like elastic modulus of 15 kPa with mimicry of the extracellular matrix is reported. Engineering this unique set of properties is enabled by a novel in‐scaffold polymerization approach. Colloidal hydrogels of the nanoclay Laponite are employed as supports for the assembly of secondary polymer networks. Laponite dramatically increases the conductivity of in‐scaffold polymerized poly(ethylene‐3,4‐diethoxy thiophene) in the absence of other dopants, while preserving excellent stretchability. The scaffold is coated with a layer containing adhesive peptide and polysaccharide dextran sulfate supporting the attachment, proliferation, and neuronal differentiation of human induced pluripotent stem cells directly on the surface of conductive hydrogels. Due to its compatibility with simple extrusion printing, this material promises to enable tissue‐mimetic neurostimulating electrodes.
- 9 March 2017
- Published by Wiley in Advanced Functional Materials
- Vol. 27 (15)
In Vivo Examination of an Injectable Hydrogel System Crosslinked by Peptide–Oligosaccharide Interaction in Immunocompetent Nude Mice
Hydrogels can serve as matrices to mimic natural tissue function and be used for wide‐ranging applications such as tissue regeneration and drug delivery. Injectable hydrogels are particularly favorable because their uses are minimally invasive. However, creating moldable substance for injection often results in compromised function and stability. This study reports an injectable hydrogel system crosslinked by peptide–oligosaccharide noncovalent interaction. The dynamic network shows fast self‐healing, a property essential for injectability. Injected hydrogels in immunocompetent mice and release of encapsulated compound are monitored up to 9 months by magnetic resonance imaging (MRI) and optical imaging. This surprisingly stable hydrogel does not cause adverse inflammatory response, as analyzed by measuring cytokine levels, immunohistochemistry, and MRI. Hydrogel degradation is associated with invasion of macrophages and vascular formation. The facile synthesis, high biocompatibility, and stability of this injectable hydrogel can lead to various experimental and clinical applications in regenerative medicine and drug delivery.
- 9 March 2017
- Published by Wiley in Advanced Functional Materials
- Vol. 27 (15)
In Vivo Examination of an Injectable Hydrogel System Crosslinked by Peptide–Oligosaccharide Interaction in Immunocompetent Nude Mice
Hydrogels can serve as matrices to mimic natural tissue function and be used for wide‐ranging applications such as tissue regeneration and drug delivery. Injectable hydrogels are particularly favorable because their uses are minimally invasive. However, creating moldable substance for injection often results in compromised function and stability. This study reports an injectable hydrogel system crosslinked by peptide–oligosaccharide noncovalent interaction. The dynamic network shows fast self‐healing, a property essential for injectability. Injected hydrogels in immunocompetent mice and release of encapsulated compound are monitored up to 9 months by magnetic resonance imaging (MRI) and optical imaging. This surprisingly stable hydrogel does not cause adverse inflammatory response, as analyzed by measuring cytokine levels, immunohistochemistry, and MRI. Hydrogel degradation is associated with invasion of macrophages and vascular formation. The facile synthesis, high biocompatibility, and stability of this injectable hydrogel can lead to various experimental and clinical applications in regenerative medicine and drug delivery.
- Open Access
- 12 October 2016
- Published by Springer Nature in Amino Acids
- Vol. 49 (1) , 183-191
Insights into binding of S100 proteins to scavenger receptors: class B scavenger receptor CD36 binds S100A12 with high affinity
The EF-hand type calcium-binding protein S100A12 exerts numerous intra- and extracellular functions of (patho)physiological relevance. Therefore, receptors of S100A12 are of high interest for research and clinical applications. Beside the extensively studied receptor for advanced glycation endproducts (RAGE), G-protein coupled receptors and more recently, scavenger receptors are suggested to be putative S100A12 receptors. Own findings and further information from the literature predestined CD36, a class B scavenger receptor, as promising candidate. To substantiate or prove against this hypothesis, this study aimed at investigation of interaction of S100A12 and CD36 on molecular and cellular level by the use of surface plasmon resonance (SPR), radio- and fluorescence-tracer-based cell binding, and cell activation experiments. S100A12 revealed binding affinity to CD36 in the low nanomolar range, essentially, at the CD36 thrombospondin-1 binding site. Additionally, S100A12-mediated translocation of CD36 to the membrane and elevation of both CD36 and peroxisome proliferator-activated receptor γ (PPARγ) expression was observed, which suggest a potential regulatory function of S100A12–CD36 interaction.
- 12 October 2016
- Published by Springer Nature in Amino Acids
- Vol. 49 (1) , 183-191
Open AccessInsights into binding of S100 proteins to scavenger receptors: class B scavenger receptor CD36 binds S100A12 with high affinity
The EF-hand type calcium-binding protein S100A12 exerts numerous intra- and extracellular functions of (patho)physiological relevance. Therefore, receptors of S100A12 are of high interest for research and clinical applications. Beside the extensively studied receptor for advanced glycation endproducts (RAGE), G-protein coupled receptors and more recently, scavenger receptors are suggested to be putative S100A12 receptors. Own findings and further information from the literature predestined CD36, a class B scavenger receptor, as promising candidate. To substantiate or prove against this hypothesis, this study aimed at investigation of interaction of S100A12 and CD36 on molecular and cellular level by the use of surface plasmon resonance (SPR), radio- and fluorescence-tracer-based cell binding, and cell activation experiments. S100A12 revealed binding affinity to CD36 in the low nanomolar range, essentially, at the CD36 thrombospondin-1 binding site. Additionally, S100A12-mediated translocation of CD36 to the membrane and elevation of both CD36 and peroxisome proliferator-activated receptor γ (PPARγ) expression was observed, which suggest a potential regulatory function of S100A12–CD36 interaction.